Question 1

Does Schonfeld Strategic Advisors own IMVT stock?

Accepted Answer

No. Schonfeld Strategic Advisors exited its IMVT (Immunovant) position in Q2 2026. Its Q1 2026 13F listed 33,553 shares worth $833,456.

Question 2

How many shares of IMVT does Schonfeld Strategic Advisors own?

Accepted Answer

None since Q2 2026, when Schonfeld Strategic Advisors exited the position. Its Q1 2026 13F listed 33,553 shares worth $833,456.

Question 3

What is Schonfeld Strategic Advisors' IMVT position worth?

Accepted Answer

Schonfeld Strategic Advisors' IMVT position was worth $833,456 in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Schonfeld Strategic Advisors buying or selling IMVT?

Accepted Answer

In Q2 2026, Schonfeld Strategic Advisors exited its entire IMVT position.

Question 5

When did Schonfeld Strategic Advisors first buy IMVT?

Accepted Answer

Schonfeld Strategic Advisors first reported IMVT in its Q4 2019 13F and listed it in 15 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$38.53	0
2026-Q1	New	33,553	—	$833,456	0.0%	$26.71	34
2025-Q4	Exited	0	-100.0%	$0	0.0%	$25.42	0
2025-Q3	New	115,750	—	$1.9M	0.0%	$16.12	36
2024-Q4	Exited	0	-100.0%	$0	0.0%	$24.77	0
2024-Q3	Increased	98,274	+342.1%	$2.8M	0.0%	$28.02	42